Loading company…
THE PHAGE develops AI-based tools for glucose management and supports medical research and development.
Founded in 2021 in Tokyo, THE PHAGE develops medical devices and research services, including an app that uses biometric data to help users manage blood glucose levels. The app analyzes individual data and provides lifestyle recommendations. In February 2026, the company raised an undisclosed amount in venture funding from Fukui Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in